Post Profile






Bristol-Myers Squibb claims 'breakthrough' lung-cancer treatment

Bristol-Myers Squibb is claiming a "breakthrough" in lung-cancer research with a potential alternative treatment to chemotherapy.        
read more

share

Related Posts


NYITCOM Researcher Discovers Potential Cancer Treatment Breakthrough

Health : Newswise Medical News

Patients undergoing conventional chemotherapy for certain cancers could potentially receive more effective and less toxic drug treatment.

Tarceva (erlotinib) Good Alternative To Chemotherapy For Some Lung Cancer Patients, UK

Health : Medical News Today

According to today's announcement by Roche, Tarceva (erlotinib), an oral lung cancer treatment, has been officially licensed as first-line monotherapy for the treatment of patients with advanced forms of non-small cell lung cancer (...

Roche lung cancer drug success adds to pressure on Bristol

Health : Reuters: Health

COPENHAGEN (Reuters) - Lung cancer patients on Roche's immune system-boosting drug Tecentriq lived on average 4.2 months longer than those taking chemotherapy in a pivotal study, pressuring Bristol-Myers Squibb's dominant position i...

Bristol's Opdivo Disappoints in Lung Cancer, While Merck's Keytruda Surprises

Business & Finance : Forbes: Business

FindTheCompany | Graphiq Shares of Bristol-Myers Squibb have fallen 26% since August, when a large study of lung cancer patients failed to demonstrate that its breakthrough cancer drug, Opdivo, could slow tumor growth or extend pati...

Breakthrough Drug Extensively Evaluated by UCLA Scientist Approved as Alternative to Chemotherapy for People with Advanced Lung Cancer

Health : Newswise Medical News

Pembrolizumab, an immunotherapy drug that was extensively evaluated by UCLA cancer researcher Dr. Edward Garon, has been approved by the U.S. Food & Drug Administration as first-line treatment for non-small cell lung cancer (NSCLC)....

Comments


Copyright © 2016 Regator, LLC